1. Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med 2020. published online Jan 24. https://doi.org/:10.1056/NEJMoa2001017.
2. Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 2020; 395: 507-513. https://doi.org/10.1016/S0140-6736(20)30211-7.
3. Wang D, Hu B, Hu C, ZhuF, LiuX, ZhangJ, et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China. JAMA 2020; 323: 1061-1069. https://doi.org/10.1001/jama.2020.1585.
5. Ji D, Qin E, Xu J, Zhang D, Cheng G, Wang Y, et al. . Non-alcoholic fatty liver diseases in patients with COVID-19: A retrospective study. J Hepatol 2020; published online Apr 8. https://doi.org/10.1016/j.jhep.2020.03.044.
6. Ji D, Zhang D, Xu J, Chen Z, Yang T, Zhao P, et al. Prediction for progression risk in patients with COVID-19 pneumonia: the CALL score. Clin Infect Dis 2020; published online Apr 9.
https://doi.org/10.1093/cid/ciaa414.
7. Alsaad KO, Hajeer AH, Balwi MA, Moaiqel MA, Oudah NA, Ajlan AA, et al. Histopathology of Middle East respiratory syndrome coronovirus (MERS-CoV) infection-clinicopathological and ultrastructural study. Histopathology 2018; 72: 516-524. https://doi.org/10.1111/his.13379.
8. Chau TN, Lee KC, Yao H, Tsang TY, Chow TC, Yeung YC, et al. SARS-associated viral hepatitis caused by a novel coronavirus: report of three cases. Hepatology 2004; 39: 302–10. https://doi.org/10.1002/hep.20111.
9. Hoffmann M, Kleine-Weber H, Krueger N, Müller M, Drosten C, Pöhlmann S, et al. The novel coronavirus 2019 (2019-nCoV) uses the SARS-coronavirus receptor ACE2 and the cellular protease TMPRSS2 for entry into target cells. BioRxiv 2020; 01.31.929042. https://doi.org/10.1101/2020.01.31.929042.
10. Zhou P, Yang X, Wang X, Wang X, Hu B, Zhang L, Zhang W, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 2020; 579: 270-273. https://doi.org/10.1038/s41586-020-2012-7.
11. Cai Q, Huang D, Yu H, Zhu Z, Xia Z, Su Y, et al. COVID-19: abnormal liver function tests. J hepatol 2020; S0168-8278(20)30218-X. https://doi.org/ 10.1016/j.jhep.2020.04.006.
12. Guan W, Ni Z, Hu Y, Liang W, Ou C, He J, et al. Clinical characteristics of 2019 novel coronavirus infection in China. N Engl J Med 2020; 382:1708-1720. https://doi.org/10.1056/NEJMoa2002032.
13. Shi H, Han X, Jiang N, Cao Y, Alwalid O, Gu J, et al. Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study. Lancet Infect Dis. 2020; 20: 425-434. https://doi.org/ 10.1016/S1473-3099(20)30086-4.
14. Yang X, Yu Y, Xu J, Shu H, Xia J, Liu H, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med 2020; 8:475-481. https://doi.org/10.1016/S2213-2600(20)30079-5.
18. National Health Commission (NHC) of the PRC and National Administration of Traditional Chinese Medicine of the PRC. Guidance for Corona Virus Disease 2019: Prevention, Control, Diagnosis and Management. Peoples Medical Publishing House 2020. http://www.pmph.com/.
19. Zhang C, Shi L, Wang FS. Liver injury in COVID-19: management and challenges. Lancet Gastroenterol Hepatol 2020; 5:428-430. https://doi.org/10.1016/S2468-1253(20)30057-1.
20. Chai X, Hu L, Zhang Y, Han W, Lu Z, Ke A, et al. Specific ACE2 expression in cholangiocytes may cause liver damage after 2019-nCoV infection. BioRxiv 2020. https://doi.org/10.1101/2020.02.03.931766.
21. Duan Z, Chen Y, Zhang J, Zhao J, Lang Z, Meng F, et al. Clinical characteristics and mechanism of liver injury in patients with severe acute respiratory syndrome. Chin J Hepatol 2003,11: 493-496.
22. Ruan Q, Yang K, Wang W, Jiang L, Song J. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med 2020; 46:846-848. https://doi.org/ 10.1007/s00134-020-06028-z.
23. Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult in patients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 2020; 395: 1054-1062. https://doi.org/ 10.1016/S0140-6736(20)30566-3.